o2h Ventures

VC🇬🇧 United Kingdom

Investment thesis

FCA-authorised specialist SEIS/EIS fund manager focused on UK biotech and AI-enabled human health companies developing next-generation therapeutics and drug-discovery platforms. Edge comes from a proprietary 2.7-acre science park enabling incubation and early deal access.

Notable portfolio

Hawkhill TherapeuticsHelusEnedra TherapeuticsExonatePharmEnableTurbineBiVictriX Therapeutics

Sector focus

BiotechLife sciencesAI-driven drug discoveryTherapeuticsTechBioAI Drug DiscoveryBiotech therapeuticsAI/ML in biotechNovel drug discoveryAI/ML for drug discoveryDigital therapeuticsEnabling servicesAI in human healthDrug discoveryGenomics